ISPC logo

ISPC iSpecimen Inc.

NASDAQ Capital Market · Medical - Diagnostics & Research · Healthcare

$0.53
-0.06 (-10.57%)

iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a …

Market Cap: $1.34Mispecimen.com

Price

$2.22-48.01%
$1.83$3.20$4.56$5.93
Apr 29Aug 7

Social Signal Score

41
5d
50
1 mentions
+0.0%
30d
35
2 mentions
+0.0%
60d
40
3 mentions
+0.0%
90d
40
3 mentions
+0.0%
news: 3

Analyst Ratings

2 analysts
Buyconsensus
Strong Buy 0Buy 2Hold 0Sell 0Strong Sell 0

Revenue

$244.0K-64.77%
$51.8K$1.02M$1.99M$2.96M
Sep 2019Sep 2026

Analyst Estimates

FY2025
$-632.00
$-632.00–$-632.00
1 analysts
FY2026
$0.00
$0.00–$0.00
0 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Shahin Behroyan
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
7
Beta
1.65
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
-16.10
ispecimen.com